Chongqing Xishan Science & Technology Co., Ltd. (SHA:688576)

SHA:688576 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	306.53	341.99	336.38	360.69	262.27	208.86
Revenue Growth	-9.85%	1.67%	-6.74%	37.52%	25.57%	63.97%
Gross Profit Gross Profit Growth	181.08	210.22	233.43	247.34	179.02	145.47
Operating Income Operating Income Growth	-25.54	26	65.33	90.38	62.7	49.75
Net Income Net Income Growth	-7.94	51.91	98.67	117.34	75.35	61.43
Earnings Per Share EPS Growth	-0.12	0.77	1.32	1.70	1.28	1.12
EPS Growth	-	-41.62%	-22.14%	33.16%	13.92%	265.34%

Revenue by Segment

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Medical Instruments Medical Instruments Growth	337.02
Other Other Growth	4.05
Total Total Growth	341.06

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	622.75	725.1	993.02	1,586	332.89	304.24
Total Debt Total Debt Growth	-	-	0.13	3.09	6.17	9.43
Net Cash (Debt) Net Cash Growth	622.75	725.1	992.89	1,583	326.72	294.8
Net Cash Growth	-27.69%	-26.97%	-37.29%	384.60%	10.82%	194.20%
Net Cash Per Share Net Cash Per Share Growth	9.29	10.78	13.30	22.91	5.53	5.37

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	-9.53	60.03	39.47	68.08	79.1	55.88
Capital Expenditures CapEx Growth	-64.31	-96	-157.55	-103.72	-49.15	-14.18
Free Cash Flow Free Cash Flow Growth	-73.84	-35.96	-118.08	-35.64	29.95	41.7
Free Cash Flow Growth	-	-	-	-	-28.17%	26.18%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	59.07%	61.47%	69.39%	68.57%	68.26%	69.65%
Operating Margin	-8.33%	7.60%	19.42%	25.06%	23.91%	23.82%
Pretax Margin	-3.04%	15.52%	33.11%	35.23%	28.48%	29.13%
Profit Margin	-2.59%	15.18%	29.33%	32.53%	28.73%	29.41%
FCF Margin	-24.09%	-10.51%	-35.10%	-9.88%	11.42%	19.96%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Dividend Per Share Dividend Per Share Growth	0.336	0.336	0.671	0.671
Dividend Per Share Growth	-25.50%	-49.99%	0%	-
Dividend Yield	0.85%	0.80%	1.65%	1.08%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	54.81	27.30	43.42	-	-
Forward PE	-	17.59	18.32	33.49	-	-
PS Ratio	8.53	8.32	8.01	14.13	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error